Baader Bank Aktiengesellschaft Lowers Holdings in Danaher Corporation $DHR

Baader Bank Aktiengesellschaft reduced its position in Danaher Corporation (NYSE:DHR) by 28.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,045 shares of the conglomerate’s stock after selling 4,068 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in Danaher were worth $1,904,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Bank Pictet & Cie Europe AG raised its holdings in Danaher by 25.4% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock valued at $83,895,000 after buying an additional 74,301 shares during the period. Defender Capital LLC. purchased a new stake in shares of Danaher in the 4th quarter valued at approximately $35,715,000. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after acquiring an additional 186,584 shares during the last quarter. Peak Financial Advisors LLC lifted its holdings in shares of Danaher by 215.4% in the 4th quarter. Peak Financial Advisors LLC now owns 10,638 shares of the conglomerate’s stock worth $2,435,000 after acquiring an additional 7,265 shares during the last quarter. Finally, SeaBridge Investment Advisors LLC purchased a new position in shares of Danaher during the 4th quarter worth approximately $4,477,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Down 1.0%

Shares of Danaher stock opened at $201.70 on Tuesday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a market capitalization of $142.76 billion, a P/E ratio of 39.01, a P/E/G ratio of 2.51 and a beta of 0.79. The company has a 50 day moving average of $183.97 and a 200 day moving average of $198.04.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the company posted $1.88 earnings per share. Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, research analysts forecast that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.

Analyst Ratings Changes

DHR has been the topic of a number of research reports. JPMorgan Chase & Co. decreased their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. TD Cowen dropped their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Morgan Stanley cut their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Argus decreased their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Finally, Piper Sandler initiated coverage on Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $231.64.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.